Impinj and Sartorius Join Forces to Drive Innovation in Biopharmaceutical Manufacturing
- Sartorius will host its inaugural PI Forum on June 24-26, 2025, focusing on biomanufacturing advancements.
- The forum aims to catalyze change through collaboration, featuring presentations and hands-on workshops on Sartorius' PI solutions.
- Sartorius emphasizes its commitment to innovation and partnerships to transform biopharmaceutical manufacturing and enhance sustainability.
Sartorius PI Forum Set to Transform Biopharmaceutical Manufacturing
Sartorius, a key player in life science research and biopharmaceuticals, announces its inaugural Sartorius PI Forum, scheduled for June 24-26, 2025, at the Royal Sonesta Boston. This event aims to convene leaders and innovators in biomanufacturing to explore process intensification (PI), particularly regarding protein therapeutics and emerging modalities. Maurice Phelan, President of Sartorius North America, emphasizes that the forum is designed not just to discuss advancements but to catalyze actionable change and promote collaboration among stakeholders in the biomanufacturing ecosystem.
The forum will feature a robust agenda that includes data-driven presentations from industry experts, hands-on workshops, and live demonstrations of Sartorius' latest PI solutions. With a focus on bridging the gap between strategic discussions and practical applications, the event will explore how innovations in flexible manufacturing, digitalization, automation, and sustainability can enhance drug development and production efficiency. Miriam Monge, Head of Customer & Industry Advocacy Strategy BPS at Sartorius, highlights that process intensification plays a crucial role in improving the speed, scale, and sustainability of drug manufacturing, aligning closely with the industry's evolving needs.
As the biopharmaceutical landscape continues to evolve, the Sartorius PI Forum represents a pivotal moment for the industry. By connecting innovative minds and resources, the event aims to redefine best practices in biomanufacturing and accelerate the development of next-generation therapies. Participants will gain valuable insights into cutting-edge technologies and trends, reinforcing Sartorius' commitment to leading the charge in transforming drug manufacturing processes.
In addition to the forum, Sartorius underscores its ongoing efforts to drive advancements in biopharmaceutical manufacturing through strategic partnerships and collaborations. By fostering an environment that encourages innovation and shared knowledge, Sartorius aims to position itself at the forefront of industry transformation.
Overall, the Sartorius PI Forum stands as a significant initiative in the biopharmaceutical sector, aiming to facilitate the future of biologics through enhanced collaboration and a focus on sustainable manufacturing practices.
